Abstract
Schistosomiasis is a debilitating parasitic disease, affects large number of host species. Currently affects 250–300 million people in tropic areas. Schistosoma pathogenic impact is hepatic periportal fibrosis; the parasite-induced inflammatory cellular activation promotes oxidative stress, resulting in lipid peroxidation (LPO), with subsequent increase in inflammatory mediators as malondialdehyde (MDA). This study was set up to reveal possible contribution of lipid peroxidation byproducts MDA in hepatic pathophysiology. Results displayed that MDA don’t tend to change in relation with either age, nor hepatic transaminases AST & ALT, while exhibited a significant increase in MDA levels in human schistosomiasis versus control group P<0.0001 (Mn. ± St.dev. 7.77 ± 3.59, 1.21 ± 0.28 nmol/ml) respectively. Moreover; MDA plasma levels in Schistosoma infected group correlated significantly with two hepatic fibrosis parameters; (a) ultrasonography graded periportal fibrosis P< 0.0001. Levels of MDA in hepatic fibrosis grades 0, I, II, III in Schistosoma infected group were (Mn. ± St.dev. 2.8 ± 0.64, 4.3 ± 1.2, 9.3 ± 1.6 and 10.8 ± 1.3 nmol/ml) respectively, (b) serum Hyaluronic acid (HA) P<0.0001 (spearman r = 0.77) as a reliable hepatic fibrosis marker. This implies a considerable role of LPO byproducts in schistosomiasis pathogenicity, and proposing malondi-aldehyde as a biomarker for schistosomiasis morbidity.
Similar content being viewed by others
References
Abdallahi O.M., Hanna S., De Reggi M., Gharib B. 1999. Visualization of oxygen radical production in mouse liver in response to infection with Schistosoma mansoni. Liver, 19, 495–500
Abou-El-Naga I.F., 2013. Biomphalaria alexandrina in Egypt: Past, present and future. Journal of Biosciences, 38, 665–672. DOI: 10.1007/s12038-013-9329-4
Barros A.F., Oliveira S.A., Carvalho C.L., Silva F.L., de Souza V.A., Da Silva A.L., De Araujo R.E., Souza, B.S., Soares M.B.P., Costa V.M., Coutinho E.D. 2014. Low transformation growth factor-ß1 production and collagen synthesis correlate with the lack of hepatic periportal fibrosis development in undernourished mice infected with Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 109, 210–219. DOI: 10.1590/0074-0276140266
Coutinho E.M., Silva F.L., Barros A.F., Araújo R.E., Oliveira S.A.L., Carlos F.B., Aryon A.A., Zilton A. 2007. Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice. Acta Tropica, 101, 15–24. DOI: 10.1016/j.actat-ropica.2006.03.006
Coutinho H.M., McGarvey S.T., Acosta L.P., Manalo D.L., Langdon G.C., Leenstra T., Kanzaria H.K., Solomon J., Wu H., Olveda R., Kurtis J.D., Friedman J.F. 2005. Nutritional status and serum cytokine profiles in children, adolescents, and young adults with Schistosoma japonicum-associated hepatic fibro-sis, in Leyte, Philippines. The Journal of Infectious Diseases, 192, 528–36. DOI: 10.1086/430929
Cunha G.M., Silva V.M.A., Bessa K.D.G., Bitencourt M.A.O., Macêdo U.B.O., Freire-Neto F.P., Martins R.R., Assis C.F., Lemos T.M.A.M., Almeida M.G., Freire A.C.G. 2012. Levels of oxidative stress markers: correlation with hepatic function and worm burden patients with schistosomiasis. Acta Parasitologica, 57, 160–166. DOI: 10.2478/s11686-012-0026-5
Dessein A.J., Marquet S., Henri S.E.I., Wali N.E., Hillaire D., Rodrigues V., Prata A., Ali Q.M., Gharib, B., de Reggi M., Magzoub M.M., Saeed O.K., Abdelhameed A.A., Abel L. 1999. Infection and disease in human schistosomiasis mansoni are under distinct major gene control. Microbes and Infection, 1, 561–567
Domingues A.L.C., Medeiros T.B., Lopes E.P. de A. 2011. Ultrasound versus biological markers in the evaluation of periportal fibrosis in human Schistosoma mansoni. Memórias do Instituto Oswaldo Cruz, 106, 802–807
Eboumbou C., Steghens J.P., Abdallahi O.M.S., Mirghani A., Gallian P., van Kappel A., Qurashi A., Gharib B., De Reggi M. 2005. Circulating markers of oxidative stress and liver fibro-sis in Sudanese subjects at risk of schistosomiasis and hepatitis. Acta Tropica, 94, 99–106. DOI: 10.1016/j.actatropica. 2005.03.001
Elsammak M.Y., Al-Sharkaweey R.M., Ragab M.S., Amin G.A., Kandil M.H. 2008. IL-4 and reactive oxygen species are elevated in Egyptian patients affected with schistosomal liver disease. Parasite Immunology, 30, 603–609. DOI: 10.1111/j.1365-3024.2008.01061.x
Esterbauer H., Schaur R.J., Zollner H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology and Medicine, 11, 81–128
Esterbauer H. 1993. Cytotoxicity and genotoxicity of lipidoxidation products. The American Journal of Clinical Nutrition, 57, 779S–785S
Facundo H.T.F., Brandt C.T., Owen J.S., Lima V.L.M. 2004. Elevated levels of erythrocyte-conjugated dienes indicate increased lipid peroxidation in schistosomiasis mansoni patients. Brazilian Journal Of Medical and Biological Research, 37, 957–962. DOI: /S0100-879X2004000700003
Gil L., Siems W., Mazurek B., Gross J., Schroeder P., Voss P., Grune T. 2006. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes. Free Radic Res, 40, 495–505. DOI: 10.1080/10715760600592962
Gordon C.C., and Alimuddin I.Z. 2003. Manson’s Tropical Diseases. W.B. Saunders, USA, Philadelphia
Grigorescu M., 2006. Noninvasive Biochemical Markers of Liver Fibrosis. Journal of Gastrointestinal and Liver Diseases, 15, 149–159
Gutteridge J.M., Halliwell B. 1990. The measurement and mechanism of lipid peroxidation in biological systems. Trends in Biochemical Sciences, 15, 129–135
Halfon P., Bourlière M., Pénaranda G., Deydier R., Renou C., Botta-Fridlund D., Tran A., Portal I., Allemand I., Rosenthal-Allieri A., Ouzan D. 2005. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comparative Hepatology, 4, 6. DOI: 10.1186/1476-5926-4-6
Hotez P.J., Molyneux D.H., Fenwick A., Ottesen E., Ehrlich Sachs S., Sachs Je. D. 2006. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med, 3, e102. DOI: 10. 1371/journal.pmed.0030102
King C.H., Dickman K., Tisch D.J. 2005. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet, 365, 1561–1569. DOI: 10.1016/S0140-6736(05)66457-4
Köpke-Aguiar L., Martins J.R., Passerotti C., Toledo C.F., Nader H.B., Borges D.R. 2002. Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schisto-somiasis. Acta Tropica, 84, 117–126. DOI: 10.1016/S0001-706X(02)00136-5
Lefèvre G., Beljean-Leymarie M., Beyerle F., Bonnefont-Rousselot D., Cristol J.P., Thérond P., Torreilles J. 1998. Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances. Annales De Biologie Clinique (Paris), 56, 305–319
Maia M.D., Lopes E.P.A., Ferraz A.A.B., Barros, Fábio M.R., Domingues A.L.C., Ferraz E.M. 2007. Evaluation of splenomegaly in the hepatosplenic form of mansonic schistoso-miasis. Acta Tropica, 101, 183–186. DOI: 10.1016/j.actat-ropica.2007.01.004
Marnett L.J. 2000. Oxyradicals and DNA damage. Carcinogenesis, 21, 361–370. DOI:10.1093/carcin /21.3.361
Mendoza-Núñez V.M., Ruiz-Ramos M., Sánchez-Rodríguez M., Retana-Ugalde R., Muñoz-Sánchez J.L. 2007. Aging-related oxidative stress in healthy humans. Tohoku Journal of Experimental Medicine, 213, 261–268. DOI: 10.1620/tjem.213.261
Nielsen F., Mikkelsen B.B., Nielsen J.B., Andersen H.R. 1997. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry, 1214, 1209–1214
Pearce E.J., MacDonald A.S. 2002. The immunobiology of schistosomiasis. Nature Reviews Immunology, 2, 499–511. DOI: 10.1038/nri843
Pontinha N., Pessegueiro H., Barros H. 1999. Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B. Scandinavian Journal of Clinical and Laboratory Investigation, 59 343–347
Richter J., Lúcia A., Domingues C., Barata C.H., Prata A.R., Lambertucci J.R., 2001. Report of the Second Satellite Symposium on Ultrasound in Schistosomiasis. Memórias do Instituto Oswaldo Cruz, 96, 151–156
Richter J., 2000. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: a review of ultrasonographic studies. Acta Tropica, 77, 111–131
Santos V.N. dos., Leite-Mór M.M.B., Kondo M., Martins J.R., Nader H., Lanzoni V.P., Parise E.R. 2005. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Brazilian Journal Of Medical and Biological Research, 38, 747–753. DOI: 10.1590/S0100-879X200 5000500012
Sies H., Cadenas E., Symons M.C.R., Scott G., 1985. Oxidative Stress: Damage to Intact Cells and Organs [and Discussion]. Philosophical Transactions of the Royal Society B: Biological Sciences, 311, 617–631. DOI: 10.1098/rstb.1985.0168
Taccone-Gallucci M., Lubrano R., Meloni C., Morosetti M., Adolfo C.M.C.C. 1998. Malonyldialdehyde content of cell membranes is the most important marker of oxidative stress in haemodialysis patients. Nephrology Dialysis Transplantation, Oct; 13, 2711–2712
Vanheule E., Geerts A.M., Van Huysse J., Schelfhout D., Praet M., Van Vlierberghe H., De Vos M., Colle I. 2008. An intravital microscopic study of the hepatic microcirculation in cirrhotic mice models: relationship between fibrosis and angiogenesis. International Journal of Experimental Pathology, 89, 419–432. DOI: 10.1111/j.1365-2613.2008.00608.x
Zhou X.N., Wang L.Y., Chen M.G., Wu X.H., Jiang Q.W., Chen X.Y., Zheng J. Utzinger J. 2005. The public health significance and control of schistosomiasis in China—then and now. Acta Tropica, 96, 97–105. DOI: 10.1016/j.actatropica.2005. 07.005
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdel Aziz, I., Yacoub, M., Rashid, L. et al. Malondialdehyde; Lipid peroxidation plasma biomarker correlated with hepatic fibrosis in human Schistosoma mansoni infection. Acta Parasit. 60, 735–742 (2015). https://doi.org/10.1515/ap-2015-0105
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1515/ap-2015-0105